These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17604416)

  • 1. Principles of data mining.
    Hand DJ
    Drug Saf; 2007; 30(7):621-2. PubMed ID: 17604416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal detection in the pharmaceutical industry: integrating clinical and computational approaches.
    Hauben M
    Drug Saf; 2007; 30(7):627-30. PubMed ID: 17604418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on the use of data mining in pharmaco-vigilance.
    Almenoff J; Tonning JM; Gould AL; Szarfman A; Hauben M; Ouellet-Hellstrom R; Ball R; Hornbuckle K; Walsh L; Yee C; Sacks ST; Yuen N; Patadia V; Blum M; Johnston M; Gerrits C; Seifert H; Lacroix K
    Drug Saf; 2005; 28(11):981-1007. PubMed ID: 16231953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of triage strategies in the WHO signal-detection process.
    Lindquist M
    Drug Saf; 2007; 30(7):635-7. PubMed ID: 17604420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision support methods for the detection of adverse events in post-marketing data.
    Hauben M; Bate A
    Drug Discov Today; 2009 Apr; 14(7-8):343-57. PubMed ID: 19187799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccination and multiple sclerosis: a data mining perspective.
    Hauben M; Sakaguchi M; Patadia V; M Gerrits C
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):943-5. PubMed ID: 17636551
    [No Abstract]   [Full Text] [Related]  

  • 7. Signal detection: historical background.
    Egberts TC
    Drug Saf; 2007; 30(7):607-9. PubMed ID: 17604412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of stratification on adverse drug reaction surveillance.
    Hopstadius J; Norén GN; Bate A; Edwards IR
    Drug Saf; 2008; 31(11):1035-48. PubMed ID: 18840023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?
    Trifirò G; Coloma PM; Rijnbeek PR; Romio S; Mosseveld B; Weibel D; Bonhoeffer J; Schuemie M; van der Lei J; Sturkenboom M
    J Intern Med; 2014 Jun; 275(6):551-61. PubMed ID: 24635221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arthritis, Rheumatism and Aging Medical Information System Post-Marketing Surveillance Program.
    Singh G
    J Rheumatol; 2001 May; 28(5):1174-9. PubMed ID: 11361209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmarketing surveillance and other epidemiologic uses of drug prescription data in the United States.
    Strom BL
    Ann Ist Super Sanita; 1991; 27(2):235-7. PubMed ID: 1755576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Culture counts--sustainable inpatient computerized surveillance across Duke University Health System.
    Cozart H; Horvath MM; Long A; Whitehurst J; Eckstrand J; Ferranti J
    Qual Manag Health Care; 2010; 19(4):282-91. PubMed ID: 20924248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quantification of drug risks in practice.
    Lee D; Bergman U
    WHO Reg Publ Eur Ser; 1993; 45():79-95. PubMed ID: 8442852
    [No Abstract]   [Full Text] [Related]  

  • 14. Principles of signal detection in pharmacovigilance.
    Meyboom RH; Egberts AC; Edwards IR; Hekster YA; de Koning FH; Gribnau FW
    Drug Saf; 1997 Jun; 16(6):355-65. PubMed ID: 9241490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illusions of objectivity and a recommendation for reporting data mining results.
    Hauben M; Reich L; Gerrits CM; Younus M
    Eur J Clin Pharmacol; 2007 May; 63(5):517-21. PubMed ID: 17364192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Summarizing of medicinal alerts in Ivory Coast from 2001 till 2010].
    N'Guessan-Irié AG; Yavo JC; Guillaume Amari AS; Yapi AD
    Therapie; 2012; 67(3):251-6. PubMed ID: 22874492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thoughts on signal detection in pharmacovigilance.
    Shakir SA
    Drug Saf; 2007; 30(7):603-6. PubMed ID: 17604411
    [No Abstract]   [Full Text] [Related]  

  • 18. An overview of spontaneous reporting of adverse drug reactions (ARDs) in Zimbabwe.
    Ball D
    Cent Afr J Med; 2000 Jan; 46(1):23-4. PubMed ID: 14674204
    [No Abstract]   [Full Text] [Related]  

  • 19. Data mining for signal detection of adverse event safety data.
    Chen HC; Tsong Y; Chen JJ
    J Biopharm Stat; 2013; 23(1):146-60. PubMed ID: 23331228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription-event monitoring: developments in signal detection.
    Ferreira G
    Drug Saf; 2007; 30(7):639-41. PubMed ID: 17604421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.